354 related articles for article (PubMed ID: 23708066)
1. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.
Willers H; Azzoli CG; Santivasi WL; Xia F
Cancer J; 2013; 19(3):200-7. PubMed ID: 23708066
[TBL] [Abstract][Full Text] [Related]
2. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Kehlbach R; Florczak U; Sak A; Wang S; Chen J; Lobrich M; Rodemann HP
Mol Cancer Ther; 2008 Jul; 7(7):1772-81. PubMed ID: 18644989
[TBL] [Abstract][Full Text] [Related]
3. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
[TBL] [Abstract][Full Text] [Related]
4. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
Sousa MM; Zub KA; Aas PA; Hanssen-Bauer A; Demirovic A; Sarno A; Tian E; Liabakk NB; Slupphaug G
PLoS One; 2013; 8(2):e55493. PubMed ID: 23405159
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.
Hashida S; Yamamoto H; Shien K; Ohtsuka T; Suzawa K; Maki Y; Furukawa M; Soh J; Asano H; Tsukuda K; Miyoshi S; Kanazawa S; Toyooka S
Oncol Rep; 2015 Mar; 33(3):1499-504. PubMed ID: 25607753
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
Sun Q; Guo Y; Liu X; Czauderna F; Carr MI; Zenke FT; Blaukat A; Vassilev LT
Mol Cancer Res; 2019 Dec; 17(12):2457-2468. PubMed ID: 31551253
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance.
Giroux-Leprieur E; Costantini A; Ding VW; He B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235830
[TBL] [Abstract][Full Text] [Related]
9. Personalized Radiation Therapy (PRT) for Lung Cancer.
Jin JY; Kong FM
Adv Exp Med Biol; 2016; 890():175-202. PubMed ID: 26703805
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer stem cells: The root of resistance.
MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
[TBL] [Abstract][Full Text] [Related]
11. RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies.
Gachechiladze M; Škarda J; Soltermann A; Joerger M
Int J Cancer; 2017 Oct; 141(7):1286-1294. PubMed ID: 28477336
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
[TBL] [Abstract][Full Text] [Related]
13. Factors and molecular mechanisms of radiation resistance in cancer cells.
Alamilla-Presuel JC; Burgos-Molina AM; González-Vidal A; Sendra-Portero F; Ruiz-Gómez MJ
Int J Radiat Biol; 2022; 98(8):1301-1315. PubMed ID: 35225732
[TBL] [Abstract][Full Text] [Related]
14. Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer.
Leiser D; Samanta S; Eley J; Strauss J; Creed M; Kingsbury T; Staats PN; Bhandary B; Chen M; Dukic T; Roy S; Mahmood J; Vujaskovic Z; Shukla HD
PLoS One; 2021; 16(11):e0258951. PubMed ID: 34762666
[TBL] [Abstract][Full Text] [Related]
15. H2AX a promising biomarker for lung cancer: a review.
Matthaios D; Hountis P; Karakitsos P; Bouros D; Kakolyris S
Cancer Invest; 2013 Nov; 31(9):582-99. PubMed ID: 24164298
[TBL] [Abstract][Full Text] [Related]
16. The role of DNA repair pathways in cisplatin resistant lung cancer.
O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways.
Pan Y; Zhang Q; Atsaves V; Yang H; Claret FX
Oncogene; 2013 May; 32(22):2756-66. PubMed ID: 22797071
[TBL] [Abstract][Full Text] [Related]
18. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
19. [DNA repair pathways and non-small cell lung cancer: clinical perspectives].
Olaussen KA; Planchard D; Adam J; Soria JC
Bull Cancer; 2011 Mar; 98(3):305-22. PubMed ID: 21459711
[TBL] [Abstract][Full Text] [Related]
20. Involvement of adenosine A2B receptor in radiation-induced translocation of epidermal growth factor receptor and DNA damage response leading to radioresistance in human lung cancer cells.
Kitabatake K; Yoshida E; Kaji T; Tsukimoto M
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129457. PubMed ID: 31678144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
